Скачать или смотреть Reviva Pharmaceuticals' RECOVER Trial Findings

This segment features Dr. Laxminarayan Bhat, Ph.D., CEO of Reviva Pharmaceuticals (NASDAQ: RVPH) and Senior Life Sciences Analyst John Vandermosten.
Dr. Bhat shares primary findings of the RECOVER trial.
See our other conversations with Dr. Bhat:
1. Schizophrenia Phase III Results for Reviva Pharmaceuticals:    • Schizophrenia Phase III Results for Reviva...  
2. Reviva Pharmaceuticals’ RECOVER Trial Findings:    • Reviva Pharmaceuticals' RECOVER Trial Find...  
3. RECOVER Trial Results for Reviva Pharmaceuticals:    • RECOVER Trial Results for Reviva Pharmaceu...  
4. Reviva Pharmaceuticals RECOVER Trial Additional Findings:    • Reviva Pharmaceuticals RECOVER Trial Addit...  
5. Reviva Pharmaceuticals’ RECOVER Trial:    • Reviva Pharmaceuticals' RECOVER Trial  
6. What’s Going on With M&A in CNS?:    • What's Going on With M&A in CNS?  
7. What Are The Unmet Needs in Schizophrenia Treatment?:    • What Are the Unmet Needs in Schizophrenia ...  
8. Reviva Pharmaceuticals Upcoming RECOVER 2 Trial:    • Reviva Pharmaceuticals (RVPH) Upcoming REC...  
9. Reviva Pharmaceuticals RECOVER Topline:    • Reviva Pharmaceuticals RECOVER Topline  
10. Reviva Pharmaceuticals’ February 2024 KOL Event:    • Reviva Pharmaceuticals' February 2024 KOL ...  
11. Reviva Pharmaceuticals CEO Fireside Chat:    • Reviva Pharmaceuticals (RVPH) CEO Fireside...  

This video was recorded on February 22nd 2024 and information provided is current only as of that date.
Reviva Presentation and Additional Disclosures:
https://revivapharma.com/wp-content/u...